Campina, Fonterra cleared over lactose deal

By staff reporter

- Last updated on GMT

Related tags: New zealand, Milk, Fonterra

Dutch dairy group Campina is free to form a joint venture with New
Zealand dairy Fonterra to sell lactose for use in fine chemical
production and pharmaceuticals, says the European Commission.

The Commission cleared the venture, which brings together two of the world's top dairy firms, after finding there would be no damage to market competition.

The 50-50 venture highlights how dairy firms may look to make extra money with added value ingredients, outside of their traditional sector.

Lactose naturally makes up between two and eight per cent of solids in milk.

Campina and Fonterra will combine their pharmaceutical lactose business, as well as their divisions for selling lactose for use in fine chemicals manufacture. They will also sell lactose as an excipient - a carrier or diluting agent in drug formulations.

The venture deal, signed in late March, is expected to target the Asia Pacific region for growth, making use of Fonterra's new factory for producing inhalation grade lactose in the region.

Sales offices will be opened around the world, however.

"Campina has a strong position in Europe and Japan, while Fonterra has been very successful in building a strong position in the Asia Pacific region, and has a major supply agreement with one of the world's leading pharmaceutical companies,"​ said Andrew Ferrier, Fonterra's chief executive.

Related news

Show more

Related products

show more

Taking the lead in label-friendly dairy

Taking the lead in label-friendly dairy

Cargill | 28-Jul-2020 | Technical / White Paper

Tried-and-true ingredients that for generations have contributed to dairy’s rich, creamy consistency and sweet indulgence are being challenged by a new...

Related suppliers

Follow us

Products

View more

Webinars